Polyphenols and Overfeeding (Poly-Nut)

August 22, 2017 updated by: Hospices Civils de Lyon

Polyphenols: Protection From Overfeeding-induced Insulin Resistance?

Obesity is a complex and multifactorial disease representing a major public health challenge. Indeed, overweight and obese people carry a major risk of developing insulin resistance and type 2 diabetes mellitus. It has been demonstrated that polyphenols could be used to counteract some of the mechanisms involved in the generation of insulin resistance. The model of overfeeding represents a very good study model of the metabolic complications of obesity, since it has been shown to induce a transient state of insulin resistance in the human.

The purpose of this research is to study the effects of a overfeeding (+50% of daily caloric needs over 31 days) with or without polyphenols supplementation (2g/days over 31 days) on insulin sensitivity measured in the setting of a hyperinsulinemic euglycemic clamp and on post prandial partitioning of exogenous lipids after a test meal.

During 31 days, the volunteers will consume chocolate bars, chips, chocolate breads and cola in addition to their usual diet and will be supplemented with 2g of grape polyphenols extract or with placebo.

Study Overview

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Pierre-bénite, France, 69495
        • Rhône Alpes Human Nutrition Center (CRNH Rhône-Alpes)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Male
  • Aged from 18 to 55 years
  • Body Mass Index of 23 to 27 kg/m²
  • Normal blood pressure
  • Fasting glycemia < 7 mmol/L
  • CRPus < 10mg/L
  • Triglycerides ≤ 3mmol/L

Exclusion Criteria:

  • Medical or surgical history which may affect the results (renal -cardiovascular - hepatic- endocrine-inflammatory diseases)
  • Subjects under treatment which may interfere with the measured parameters
  • Eating disorder
  • Intensive sportive activity
  • Dairy products allergy or intolerance

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 2g of grape polyphenol extract supplement
Men will have to consume daily 2g of grape polyphenol extract during the 31 days of overfeeding.
Men will have to consume daily 2g of grape polyphenol extract during the 31 days of overfeeding.
Placebo Comparator: 2g of placebo (lactose)
Men will have to consume daily 2g of placebo during the 31 days of overfeeding.
Men will have to consume daily 2g of placebo during the 31 days of overfeeding.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peripheral insulin sensitivity
Time Frame: During 31 days
Volunteers will have peripheral and hepatic insulin sensitivity determined by using a two-stage hyperinsulinemic euglycemic clamp with stable isotopically labeled tracer infusion.
During 31 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hepatic insulin sensitivity
Time Frame: before and after the 31 days of overfeeding
Endogenous glucose production (EGP) will be determined during the last 30 minutes of the low-dose insulin infusion.
before and after the 31 days of overfeeding
Change in genes expression in adipose and muscle tissues
Time Frame: Before and after the 31 days of overfeeding
RT-PCR
Before and after the 31 days of overfeeding
Anthropometry, Fat quantification and Abdominal fat distribution
Time Frame: During 31 days
Weight, height, waist and hip circumferences, fat mass using dual x-ray absorptiometry (DEXA) and abdominal fat distribution using resonance magnetic imaging (RMI).
During 31 days
Fasting and Postprandial partitioning of exogenous lipid
Time Frame: Fasting and during all the postprandial period (0-300 minutes)
13C enrichment will be measured in blood samples and breath test during a test meal performed before and after the 31 days of overfeeding.
Fasting and during all the postprandial period (0-300 minutes)
Modification in intestinal microbiota
Time Frame: Before and after the 31 days of overfeeding
Feces analyses
Before and after the 31 days of overfeeding
Energy expenditure and substrate oxidation with indirect calorimetry
Time Frame: Fasting and during all the postprandial period (0-300 minutes)
Energy metabolism will be measured before and after the 31 days of overfeeding.
Fasting and during all the postprandial period (0-300 minutes)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Martine LAVILLE, MD, PhD, Rhône Alpes Human Nutrition Center (CRNH Rhône-Alpes)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2014

Primary Completion (Actual)

May 1, 2017

Study Completion (Actual)

May 1, 2017

Study Registration Dates

First Submitted

May 13, 2014

First Submitted That Met QC Criteria

May 20, 2014

First Posted (Estimate)

May 23, 2014

Study Record Updates

Last Update Posted (Actual)

August 23, 2017

Last Update Submitted That Met QC Criteria

August 22, 2017

Last Verified

August 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overfeeding

Clinical Trials on 2g of grape polyphenol extract

3
Subscribe